Hepatitis B virus–host interactions and novel targets for viral cure
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatitis B virus–host interactions and novel targets for viral cure
Authors
Keywords
-
Journal
Current Opinion in Virology
Volume 49, Issue -, Pages 41-51
Publisher
Elsevier BV
Online
2021-05-22
DOI
10.1016/j.coviro.2021.04.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatitis B Virus DNA Integration: In Vitro Models for Investigating Viral Pathogenesis and Persistence
- (2021) Thomas Tu et al. Viruses-Basel
- Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivo
- (2021) Lena Allweiss et al. GUT
- Hepatitis B virus cccDNA is formed through distinct repair processes of each strand
- (2021) Lei Wei et al. Nature Communications
- Conservation of the HBV RNA element epsilon in nackednaviruses reveals ancient origin of protein-primed reverse transcription
- (2021) Jürgen Beck et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy
- (2020) Michel Bazinet et al. GASTROENTEROLOGY
- Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation
- (2020) Jun Luo et al. mBio
- Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection
- (2020) Zhongji Meng et al. Frontiers in Immunology
- Hepatitis B virus entry into HepG2-NTCP cells requires clathrin-mediated endocytosis
- (2020) Charline Herrscher et al. CELLULAR MICROBIOLOGY
- JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection
- (2020) Fabien Zoulim et al. GASTROENTEROLOGY
- Nucleic Acid Polymers as “HBsAg-Targeting” Agents: High Efficacy But More Trials Are Needed!
- (2020) David Durantel et al. GASTROENTEROLOGY
- Hepatitis B Surface Antigen Seroclearance: Immune Mechanisms, Clinical Impact, Importance for Drug Development
- (2020) Issam Tout et al. JOURNAL OF HEPATOLOGY
- Epigenetic modulation in chronic hepatitis B virus infection
- (2020) Maura Dandri Seminars in Immunopathology
- A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor
- (2020) Carla Eller et al. Nature Communications
- Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation
- (2020) Lei Wei et al. Nature Microbiology
- Targeting Host Innate and Adaptive Immunity to Achieve the Functional Cure of Chronic Hepatitis B
- (2020) Sayeh Ezzikouri et al. Vaccines
- Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro
- (2020) Richard Boulon et al. ANTIVIRAL RESEARCH
- Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
- (2020) Fiona van den Berg et al. Viruses-Basel
- Bulevirtide: First Approval
- (2020) Connie Kang et al. DRUGS
- Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection
- (2019) Man Fung Yuen et al. GASTROENTEROLOGY
- Immunological cure of HBV infection
- (2019) Julia Lang et al. Hepatology International
- Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets
- (2019) Eloi R Verrier et al. GUT
- Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells
- (2019) Matthieu Blanchet et al. ANTIVIRAL RESEARCH
- Drugs in the Pipeline for HBV
- (2019) Uri Lopatin Clinics in Liver Disease
- Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
- (2019) Masashi Iwamoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-throughput screening identifies mixed lineage kinase 3 as a key host regulatory factor in Zika virus infection
- (2019) Hua Xu et al. JOURNAL OF VIROLOGY
- Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming
- (2019) Alexandre P. Bénéchet et al. NATURE
- Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure
- (2019) Tarik Asselah et al. Lancet Gastroenterology & Hepatology
- Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial
- (2019) Man-Fung Yuen et al. Lancet Gastroenterology & Hepatology
- Review article: clinical pharmacology of current and investigational hepatitis B virus therapies
- (2019) Elise J. Smolders et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- HDAC11 restricts HBV replication through epigenetic repression of cccDNA transcription
- (2019) Yifei Yuan et al. ANTIVIRAL RESEARCH
- An Assembly-Activating Site in the Hepatitis B Virus Capsid Protein Can Also Trigger Disassembly
- (2018) Shefah Qazi et al. ACS Chemical Biology
- The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals
- (2018) Ahmed Diab et al. ANTIVIRAL RESEARCH
- TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues
- (2018) Carolina Boni et al. GASTROENTEROLOGY
- Immunotherapy for Chronic Hepatitis B Virus Infection
- (2018) Antonio Bertoletti et al. Gut and Liver
- Safety and Efficacy of Vesatolimod (GS-9620) in Patients with Chronic Hepatitis B Who Are Not Currently on Antiviral Treatment
- (2018) Kosh Agarwal et al. JOURNAL OF VIRAL HEPATITIS
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection
- (2018) Adam J. Gehring et al. GASTROENTEROLOGY
- Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection
- (2018) Barbara Rehermann et al. GASTROENTEROLOGY
- Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, is a potent inhibitor of hepatitis B virus
- (2018) Kazuma Sekiba et al. HEPATOLOGY
- Hepatitis B virus core protein phosphorylation: Identification of the SRPK1 target sites and impact of their occupancy on RNA binding and capsid structure
- (2018) Julia Heger-Stevic et al. PLoS Pathogens
- Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
- (2017) Satomi Shimura et al. JOURNAL OF HEPATOLOGY
- A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation—and Beyond?
- (2017) Sabrina Schreiner et al. Viruses-Basel
- Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application
- (2017) Jianming Hu et al. Viruses-Basel
- The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation
- (2017) Quanxin Long et al. PLoS Pathogens
- Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B
- (2016) P. Marcellin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA
- (2016) Chunlan Liu et al. ANTIVIRAL RESEARCH
- Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection
- (2016) Andrew Vaillant ANTIVIRAL RESEARCH
- Improved antiviral efficacy using TALEN-mediated homology directed recombination to introduce artificial primary miRNAs into DNA of hepatitis B virus
- (2016) Timothy Dreyer et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
- (2016) Antje Blank et al. JOURNAL OF HEPATOLOGY
- New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus
- (2016) David Durantel et al. JOURNAL OF HEPATOLOGY
- Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
- (2016) Pavel Bogomolov et al. JOURNAL OF HEPATOLOGY
- Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor
- (2016) Adrien Decorsière et al. NATURE
- DNA repair targeted therapy: The past or future of cancer treatment?
- (2016) Navnath S. Gavande et al. PHARMACOLOGY & THERAPEUTICS
- Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication
- (2016) Christopher M. Murphy et al. Cell Reports
- DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus
- (2016) Yonghe Qi et al. PLoS Pathogens
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure
- (2015) Mirjam B Zeisel et al. GUT
- HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
- (2015) Michael Nassal GUT
- A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses
- (2015) Eloi R. Verrier et al. HEPATOLOGY
- Function and information content of DNA methylation
- (2015) Dirk Schübeler NATURE
- Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease
- (2015) Edward M. Kennedy et al. VIROLOGY
- Maraviroc – A CCR5 Antagonist for the Treatment of HIV-1 Infection
- (2015) Elna Van Der Ryst Frontiers in Immunology
- Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle
- (2014) Matthieu Blanchet et al. ANTIVIRAL RESEARCH
- A Randomized, Open-Label Clinical Study of Combined Pegylated Interferon Alfa-2a (40KD) and Entecavir Treatment for Hepatitis B "e" Antigen-Positive Chronic Hepatitis B
- (2014) Q. Xie et al. CLINICAL INFECTIOUS DISEASES
- Hepatitis B virus infection
- (2014) Christian Trépo et al. LANCET
- Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection
- (2014) François Habersetzer et al. LIVER INTERNATIONAL
- AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication
- (2014) Nicholas D. Weber et al. PLoS One
- Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses
- (2014) Christian Königer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
- (2014) J. Lucifora et al. SCIENCE
- Mutational profiling of the variability of individual amino acid positions in the hepatitis B virus matrix domain
- (2014) Beate Schittl et al. VIROLOGY
- Management of antiviral drug resistance in chronic hepatitis B
- (2014) Ki Bae Bang WORLD JOURNAL OF GASTROENTEROLOGY
- GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees
- (2013) Robert E. Lanford et al. GASTROENTEROLOGY
- Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
- (2013) Yi Ni et al. GASTROENTEROLOGY
- Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)
- (2013) Koichi Watashi et al. HEPATOLOGY
- Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
- (2013) Shirin Nkongolo et al. JOURNAL OF HEPATOLOGY
- Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus Nucleocapsids
- (2013) M. R. Campagna et al. JOURNAL OF VIROLOGY
- Alpha-Interferon Suppresses Hepadnavirus Transcription by Altering Epigenetic Modification of cccDNA Minichromosomes
- (2013) Fei Liu et al. PLoS Pathogens
- Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation
- (2012) Dawei Cai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
- (2012) Laura Belloni et al. JOURNAL OF CLINICAL INVESTIGATION
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
- Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression
- (2011) Iddo Bar-Yishay et al. LIVER INTERNATIONAL
- Hepatitis B virus resistance to antiviral drugs: where are we going?
- (2011) Fabien Zoulim LIVER INTERNATIONAL
- EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
- (2011) Joachim Lupberger et al. NATURE MEDICINE
- Control of hepatitis B virus at the level of transcription
- (2010) M. Quasdorff et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
- (2009) Fabien Zoulim et al. GASTROENTEROLOGY
- Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection
- (2009) Marianna Hösel et al. HEPATOLOGY
- DDX3 DEAD-Box RNA Helicase Inhibits Hepatitis B Virus Reverse Transcription by Incorporation into Nucleocapsids
- (2009) H. Wang et al. JOURNAL OF VIROLOGY
- Incorporation of Eukaryotic Translation Initiation Factor eIF4E into Viral Nucleocapsids via Interaction with Hepatitis B Virus Polymerase
- (2009) S. Kim et al. JOURNAL OF VIROLOGY
- Mechanisms of drug combinations: interaction and network perspectives
- (2009) Jia Jia et al. NATURE REVIEWS DRUG DISCOVERY
- Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function
- (2009) L. Belloni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-Scale RNAi Screen for Host Factors Required for HIV Replication
- (2008) Honglin Zhou et al. Cell Host & Microbe
- Reverse Transcriptase- and RNA Packaging Signal-Dependent Incorporation of APOBEC3G into Hepatitis B Virus Nucleocapsids
- (2008) D. H. Nguyen et al. JOURNAL OF VIROLOGY
- Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein
- (2008) Joerg Petersen et al. NATURE BIOTECHNOLOGY
- Hepatitis B viruses: Reverse transcription a different way
- (2008) Michael Nassal VIRUS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started